Page 32 - Mployee Wellness Programs News Today

The biggest trend in gene therapy development is the potential of several treatments for rare neurological diseases to move from the bench to the bedside.

Yet another study has been published showing that patients receiving care at PE-owned hospitals experienced a higher rate of hospital-acquired adverse events, like infections and falls, than patients receiving care at hospitals that are not PE-owned. The research comes as concerns about PE-owned hospitals are intensifying — from leaders both within and outside of the healthcare industry.

A recent Oliver Wyman report laid out five Affordable Care Act trends to watch, including the rise of ICHRAs and the need for a "seamless member experience."

Novartis is paying Voyager Therapeutics $100 million up front to collaborate on gene therapies for Huntington’s disease and spinal muscular atrophy. The deal builds on a relationship the companies started in 2022.

Biomarkers, electronic health records (EHR), genomic data, imaging data, labs, social media, wearable sensors, and more provide enormous new sources of RWD that can aid in new discoveries for the quality, efficacy, and safety of new drug therapies.

Expanding access to the existing mental care system alone won’t solve problems if the mechanisms for providing care are inefficient and ineffective. Access must come hand-in-hand with quality of care - which is where measurement-based care (MBC) comes into play.

Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.

There are three key trends for the healthcare industry to follow in 2024, including the rise of AI, increasing cost pressures and M&A activity, according to West Monroe.

Galapagos is a latecomer to CAR T-therapy, but the drugmaker hopes its technology for producing cell therapies at a clinical site will help it stand out. Galapagos has encouraging preliminary data from two early-stage programs and it just begun Phase 1/2 testing of its third cancer cell therapy.

It’s time to transform how government health agencies, pharmaceutical companies, hospitals and other health organizations create and deliver information to the approximately 20 million members of LGBTQ+ communities. Start with paying attention to their "chosen circles" or their trusted sources of information.